Narrative review suggests Vanilla planifolia may enhance insulin sensitivity and reduce inflammation in diabetes.

Oxidative stress is defined as an imbalance between pro-oxidant and antioxidant species, resulting in molecular and cellular damage. It is recognized as a key pathogenic mechanism contributing to the initiation and progression of diabetes. Emerging research suggests that low-grade chronic systemic inflammation plays a crucial role in the development and progression of various chronic diseases including diabetes. Vanilla planifolia, a widely valued spice known for its distinctive sweet aroma and flavor, is primarily obtained from its beans and extensively used worldwide. Vanilla planifolia is a tropical plant valued not only for its aromatic pods but also for its diverse pharmacological properties. Vanillin is the primary bioactive compound in vanilla, contributing to its distinct flavor and aroma, alongside other phenolic compounds with antioxidant properties. Vanillin regulates antioxidant and anti-inflammatory pathways by enhancing insulin sensitivity, reducing inflammation by downregulating NF-κB, and upregulating AMPK and GLUT4 translocation. This review synthesizes current findings on the therapeutic prospects of Vanilla planifolia, emphasizing its relevance as a natural source of bioactive compounds with significant implications for diabetes.